Imbalie Beauty Limited is a franchisor, retailer and service provider of skin care, nail care and other beauty products. The Company markets and distributes its own and independent health and beauty brands to its own distribution footprint of over 150 mainly franchised and owned beauty salons, independent beauty salons and selected pharmacies. The Company has approximately three main salon brands namely Placecol Skin Care Clinic, Dream Nails Beauty and Perfect 10 Nail & Body Studio. The Company offers its own skin care range, Skinderm. The Company is engaged in training of all beauty, nail technicians and hair stylists. The Company's products include cleansers, such as Placecol Clean Start Face and Body Wash; toners, such as Placecol Clarity Matt Mist; treatment serums, such as Placecol Clear Skin Therapy; moisturizers, such as Placecol Barrier Protect Day; sun protection, such as Placecol Sun Protection Spray, and exfoliators, such as Placecol Gentle Exfoliating Treatment.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.